Fosbretabulin

Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer. Fosbretabulin is a water-soluble prodrug derived from the African bush willow (Combretum caffrum) with antineoplastic activity. Fosbretabulin is dephosphorylated to its active metabolite, combretastatin A4, which binds to tubulin and inhibits microtubule polymerization, resulting in mitotic arrest and apoptosis in endothelial cells. As apoptotic endothelial cells detach from their substrata, tumor blood vessels collapse; the acute disruption of tumor blood flow may result in tumor necrosis. a microtubule destabilizing agent isolated from Combretum caffrum. It is grouped under the following drug class(es): Microtubule inhibitors. The directory classifies it as a clinical API with a semi-synthetic source/manufacturing origin. Other names for this substance include Combretastatin A-4 phosphate and Phosbretabulin. Its PubChem CID is 5351387.

CAS No 222030-63-9
Molecular Formula C18H21O8P
Molecular Weight 396.3 g/mol
Synonyms [2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate

Frequently Asked Questions